Communications scientifiques en langue anglaise du Docteur LEON Priscilla

Découvrez les communications scientifiques en langue anglaise du Docteur LEON Priscilla, spécialiste en chirurgie laparoscopique

Accès rapide :

Consulter les communications scientifiques en français du Docteur LEON Priscilla

 

15-19 Mai 2015: American urology association, 110th AUA New Orleans, Louisiana.

  • Long-term functional outcomes of augmentation cystoplasty in adult spina bifida patients: a single-center experience in a multidisciplinary team. Priscilla Léon, Emmanuel Chartier-Kastler, Morgan Rouprêt, Pierre Denys, Gilberte Robain, Véronique Phé.
  • Systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma. Seisen T, Granger B, Colin P, Léon P, Utard G, Renard-Penna R, Compérat E, Mozer P, Cussenot O, Shariat SF, Rouprêt M
  • Detection of FGFR3 mutations from urine sediment DNA to predict the risk of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma. Seisen T, Rouprêt M, Cancel-Tassin G, Léon P, Compérat E, Drouin S, Phé V, Renard-Penna R, Mozer P, Cussenot O.
  • Prognostic value of the pT3 subclassification for upper tract urothelial carcinoma of the renal pelvicalyceal system. Seisen T, Compérat E, Colin P, Léon P, Nison L, Bozzini G, Pfister C, Guy L, Ruffion A, Descotes JL, Irani J, De La Taille A, Lebret T, Shariat SF, Cussenot O, Rouprêt M.
  • Multicenter external validation of a post-operative nomogram predicting the risk of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma. Seisen T, Hupertan V, Colin P, Léon P, Bozzini G, Nison L, Phé V, Rozet F, Mozer P, Shariat SF, Cussenot O, Rouprêt M.
  • Non clear renal cell carcinomas: oncological outcome after nephron sparing surgery based on an international multicenter study. Bigot P, Bernhard JC, Gill IS, Vuong NS, Verhoest G, Flamand V, Reix B, Suer E, Gökce I, Beauval JB, Nouhaud FX, Eto M, Baco E, Matsugasumi T, Chowaniec Y, Rigaud J, Lenormand C, Pfister C, Hetet JF, Ploussard G, Roupret M, Léon P, Bakri AE, Larré S, Tillou X, Doerfler A, Descazeaud A, Koutlidis N, Schneider A, Sebe P, Ingels A, Azzouzi AR, Soulié M, Méjean A, Bensalah K, Patard JJ.
  • The subclassifiation of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery. Bigot P, Bernhard JC, Gill IS, Vuong NS, Verhoest G, Flamand V, Reix B, Suer E, Gökce I, Beauval JB, Nouhaud FX, Eto M, Baco E, Matsugasumi T, Chowaniec Y, Rigaud J, Lenormand C, Pfister C, Hetet JF, Ploussard G, Roupret M, Léon P, Bakri AE, Larré S, Tillou X, Doerfler A, Descazeaud A, Koutlidis N, Schneider A, Sebe P, Ingels A, Azzouzi AR, Soulié M, Méjean A, Bensalah K, Patard JJ.

20-24 Mars 2015 : XIXth EAU Congress 2015, Madrid.

  • Accuracy of the prostate health index versus the urinary prostate cancer antigen 3 score to predict overall and significant prostate cancer at initial biopsy. Seisen T, Rouprêt M, Brault D, Léon P, Cancel-Tassin G, Compérat E, Renard- Penna R, Mozer P, Guechot J, Cussenot O.
  • A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma. Seisen T, Granger B, Colin P, Léon P, Utard G, Renard-Penna R, Compérat E, Mozer P, Cussenot O, Shariat SF, Rouprêt M.
  • Detection of FGFR3 mutations from urine sediment DNA to predict the risk of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma. Seisen T, Rouprêt M, Cancel-Tassin G, Léon P, Compérat E, Drouin S, Phé V, Renard-Penna R, Mozer P, Cussenot O.
  • Multicenter external validation of a post-operative nomogram predicting the risk of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma. Seisen T, Hupertan V, Colin P, Léon P, Bozzini G, Nison L, Phé V, Rozet F, Mozer P, Shariat SF, Cussenot O, Rouprêt M.
  • Is laparoscopic partial nephrectomy a safe treatment option for unexpected pT3a renal cell carcinoma ? Bernhard JC, Patard JJ, Bigot P, Evren S, Vuong NS, Verhoest G, Alimi Q, Flamand V, Reix B, Beauval JB, Benoit T, Nouhaud FX, Lenormand C, Hamidi N, Cai J, Eto M, Larré S, El Bakhri A, Baco E, Ploussard G, Hung A, Koutlidis N, Schneider A, Rouprêt M, Leon P, Carrouget J, Droupy S, Marchal S, Doerfler A, Sofiane S, Matsugasumi T, Orsoni X, Descazeaud A, Pfister C, Bensalah K, Soulie M, Gill I, and the members of the kidney cancer group of the CCAFU, Paris, France.
  • From clinically localized to pT3a renal cell carcinoma: what are the predictive factors of unexpected pathologic upstaging ? Bernhard JC, Patard JJ, Bigot P, Suer E, Vuong NS, Verhoest G, Alimi Q, Flamand V, Reix B, Beauval JB, Benoit T, Nouhaud FX, Lenormand C, Hamidi N, Cai J, Eto M, Larré S, El Bakhri A, Baco E, Ploussard G, Hung A, Koutlidis N, Schneider A, Rouprêt M, Leon P, Carrouget J, Droupy S, Marchal S, Doerfler A, Seddik S, Matsugasumi T, Orsoni X, Descazeaud A, Pfister C, Bensalah K, Soulie M, Gill I, and the members of the kidney cancer group of the CCAFU, Paris, France.

9-13 Juin 2015 : IUGA : international urogynecological association, Nice.

  • Long-term functional outcomes after artificial urinary sphincter (ams 800®) implantation in female neurogenic patients with stress urinary incontinence. Phé V, Léon P, Granger B, Rouprêt M, Denys P, Bitker MO, Chartier Kastler E.

23-24 Mars 2012 : Rencontre trinationale de chirurgie pédiatrique à Colmar.

  • Botulinium toxin using in idiopathic overactive bladder. P Léon, A Binet, C Jolly, ML Poli-Mérol.

Contact

  • Clinique Urologie Royan : 222 Avenue de Rochefort, 17200 Royan, France
  • 05 46 22 24 67 (Secrétariat ouvert du lundi au vendredi de 9h à 19h)
  • contact mail Urologie Royan

Vous souhaitez en savoir plus ?

Contactez-nous